Why is Beijing Wandong Medical Technology Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 6.78%
- The company has been able to generate a Return on Capital Employed (avg) of 6.78% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of 8.66% and Operating profit at -44.67% over the last 5 years
- INTEREST(HY) At CNY 1.24 MM has Grown at 80.58%
- OPERATING CASH FLOW(Y) Lowest at CNY 85.01 MM
- ROCE(HY) Lowest at 3.33%
3
With ROE of 2.70%, it has a expensive valuation with a 1.94 Price to Book Value
- Over the past year, while the stock has generated a return of -8.01%, its profits have fallen by -21.8%
- At the current price, the company has a high dividend yield of 0.8
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -8.01% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Beijing Wandong Medical Technology Co., Ltd. for you?
Medium Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Beijing Wandong Medical Technology Co., Ltd.
-8.01%
0.65
28.63%
China Shanghai Composite
14.77%
1.01
14.58%
Quality key factors
Factor
Value
Sales Growth (5y)
8.66%
EBIT Growth (5y)
-44.67%
EBIT to Interest (avg)
55.29
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.68
Sales to Capital Employed (avg)
0.28
Tax Ratio
5.24%
Dividend Payout Ratio
58.09%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.78%
ROE (avg)
4.90%
Valuation Key Factors 
Factor
Value
P/E Ratio
72
Industry P/E
Price to Book Value
1.94
EV to EBIT
680.35
EV to EBITDA
115.04
EV to Capital Employed
3.61
EV to Sales
3.73
PEG Ratio
NA
Dividend Yield
0.77%
ROCE (Latest)
0.53%
ROE (Latest)
2.70%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Technical Movement
8What is working for the Company
NET SALES(HY)
At CNY 796.24 MM has Grown at 29.66%
RAW MATERIAL COST(Y)
Fallen by -5.02% (YoY
CASH AND EQV(HY)
Highest at CNY 6,932.55 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 3.83%
-13What is not working for the Company
INTEREST(HY)
At CNY 1.24 MM has Grown at 80.58%
OPERATING CASH FLOW(Y)
Lowest at CNY 85.01 MM
ROCE(HY)
Lowest at 3.33%
DEBT-EQUITY RATIO
(HY)
Highest at -67.93 %
Here's what is working for Beijing Wandong Medical Technology Co., Ltd.
Net Sales
At CNY 796.24 MM has Grown at 29.66%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Cash and Eqv
Highest at CNY 6,932.55 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Inventory Turnover Ratio
Highest at 3.83%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -5.02% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Beijing Wandong Medical Technology Co., Ltd.
Interest
At CNY 1.24 MM has Grown at 80.58%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Operating Cash Flow
Lowest at CNY 85.01 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Debt-Equity Ratio
Highest at -67.93 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio






